SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Income Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Expenditure | ₹478 Cr | ₹453 Cr | ₹453 Cr |
What is the latest Total Expenditure of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹478 Cr |
| Mar2024 | ₹453 Cr |
| Mar2023 | ₹453 Cr |
How is Total Expenditure of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹478 Cr | 5.48 | |
| Mar2024 | ₹453 Cr | 0.00 | |
| Mar2023 | ₹453 Cr | - | |
Compare Total Expenditure of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,612.8 Cr | -0.3% | 10.7% | 47.6% | Stock Analytics | |
| SAGILITY | ₹18,458.5 Cr | -1.5% | -4% | -2.2% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,745.3 Cr | 0.8% | -0.3% | -31.8% | Stock Analytics | |
| PRIME FOCUS | ₹17,195.4 Cr | 3.9% | -5.2% | 85% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,387.0 Cr | 0.3% | -5% | 1.7% | Stock Analytics | |
| INDEGENE | ₹12,663.0 Cr | -0.8% | 1% | -9.7% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -0.3% |
10.7% |
47.6% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses